Differential regulation of p27Kip1 depending on culture conditions and its correlation with status of p14ARF and p53

被引:0
|
作者
Kometani, Tatsuya [1 ]
Kawasaki, Yutaro [1 ]
Chibazakura, Taku [1 ]
机构
[1] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan
关键词
anchorage dependency; cell type; NPM1; p14ARF; p27(Kip1); p53; KINASE INHIBITOR P27; CYCLIN-E; P27(KIP1); CELL; EXPRESSION; DEGRADATION; PROTEASOME; GENE; TRANSCRIPTION; PATHWAY;
D O I
10.1111/gtc.12919
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
p27(Kip1) is known as a major cyclin-dependent kinase inhibitor and a tumor suppressor, and often functionally hampered at protein level. p27 protein expression levels are frequently low in various cancers and negatively correlated with malignancy of cancer. However, in our previous study, we discovered that p27 overexpression does not inhibit the proliferation of two cancer cell lines due to a functional suppression of p27 by nucleophosmin isoform 1 (NPM1); that is, a qualitative, not quantitative, suppression of p27 function occurs in these cancer cell lines. To clarify the regulation of p27 in several types of cancer, we investigated p27 function in other cancer cell lines, based on proliferation assays in those cell lines carrying doxycycline-inducible p27, and found that MDAH041 cells which express p14ARF, an antagonist of NPM1, show growth inhibition depending on p27 induction. Moreover, to investigate p27 function under anchorage-independent culture conditions, we performed soft agar colony formation assay and observed that the colony formation of some cell lines carrying wild-type p53, a major tumor suppressor, was inhibited depending on p27 induction. These results suggest that p27 function is regulated differentially among cancer cell types under anchorage-dependent and anchorage-independent culture conditions.
引用
收藏
页码:229 / 237
页数:9
相关论文
共 50 条
  • [21] Methylation of p14ARF and abnormal expression of p53 and mdm2 in colorectal cancer: Role and correlation
    Xiong, Chaoliang
    Li, Jun
    Yan, Lingxian
    Huang, Yuan
    SCIENTIFIC RESEARCH AND ESSAYS, 2010, 5 (13): : 1669 - 1675
  • [22] Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus
    Llanos, S
    Clark, PA
    Rowe, J
    Peters, G
    NATURE CELL BIOLOGY, 2001, 3 (05) : 445 - 452
  • [23] Inactivation of p14ARF and p53 are inversely correlated in human cell lines.
    Nicholson, SA
    Khan, MA
    Welsh, JA
    McMenamin, MG
    Travis, WD
    Harris, CC
    LABORATORY INVESTIGATION, 2001, 81 (01) : 212A - 212A
  • [24] Correlation between promoter methylation of p14ARF, TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma
    Liu Xiaofang
    Tang Kun
    Yu Shaoping
    Wang Zaiqiu
    Su Hailong
    World Journal of Surgical Oncology, 10
  • [25] Inactivation of p14ARF and p53 are inversely correlated in human cell lines.
    Nicholson, SA
    Khan, MA
    Welsh, JA
    McMenamin, MG
    Travis, WD
    Harris, CC
    MODERN PATHOLOGY, 2001, 14 (01) : 212A - 212A
  • [26] Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus
    Susana Llanos
    Paula A. Clark
    Janice Rowe
    Gordon Peters
    Nature Cell Biology, 2001, 3 : 445 - 452
  • [27] Correlation between promoter methylation of p14ARF, TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma
    Liu Xiaofang
    Tang Kun
    Yu Shaoping
    Wang Zaiqiu
    Su Hailong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [28] Growth suppression by a p14ARF exon 1β adenovirus in human tumor cell lines of varying p53 and Rb status
    Saadatmandi, N
    Tyler, T
    Huang, YH
    Haghighi, A
    Frost, G
    Borgstrom, P
    Gjerset, RA
    CANCER GENE THERAPY, 2002, 9 (10) : 830 - 839
  • [29] Enhanced tumor suppression by a p14ARF/p53 bicistronic adenovirus through increased p53 protein translation and stability
    Huang, YH
    Tyler, T
    Saadatmandi, N
    Lee, C
    Borgstrom, P
    Gjerset, RA
    CANCER RESEARCH, 2003, 63 (13) : 3646 - 3653
  • [30] Growth suppression by a p14ARF exon 1β adenovirus in human tumor cell lines of varying p53 and Rb status
    Neshat Saadatmandi
    Traci Tyler
    Yinghui Huang
    Ali Haghighi
    Greg Frost
    Per Borgstrom
    Ruth A Gjerset
    Cancer Gene Therapy, 2002, 9 : 830 - 839